Trial intelligence / Profile preview

Neoadjuvant TPF and Concurrent Chemoradiation for Stage IVAB NPC

NCT00816816Phase 2Unknown

Sponsor
Fudan University
Start
Feb 2007
Primary completion
Dec 2009
Modality
Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of docetaxel, Cisplatin micelle injection (HA132), fluorouracil in nasopharyngeal carcinoma (NPC), sponsored by Fudan University. Status: unknown.

02

Drugs

docetaxelCisplatin micelle injection (HA132)fluorouracil
03

Conditions

nasopharyngeal carcinoma (NPC)

Beyond the preview

Go deeper on NCT00816816.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00816816.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call